Clofarabine (Amneal Biosciences LLC)
Welcome to the PulseAid listing for the Clofarabine drug offered from Amneal Biosciences LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Amneal Biosciences LLC |
NON-PROPRIETARY NAME: | Clofarabine |
SUBSTANCE NAME: | CLOFARABINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-11-06 |
END MARKETING DATE: | 0000-00-00 |
Clofarabine HUMAN PRESCRIPTION DRUG Details:
Item Description | Clofarabine from Amneal Biosciences LLC |
LABELER NAME: | Amneal Biosciences LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2017-11-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70121-1236_03fa52bc-9691-4d08-9fc3-252bb19f8607 |
PRODUCT NDC: | 70121-1236 |
APPLICATION NUMBER: | ANDA208857 |
Other CLOFARABINE Pharmaceutical Manufacturers / Labelers: